Notices. Notice of application
517 words·~2 min read·
/register/2022/12/28/2022-28205A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4410-FY-P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-1123] Bulk Manufacturer of Controlled Substances Application: Isosciences, LLC AGENCY: Drug Enforcement Administration, Justice. ACTION: Notice of application. SUMMARY: Isosciences, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before February 27, 2023.
Such persons may also file a written request for a hearing on the application on or before February 27, 2023. ADDRESSES: The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to *https://www.regulations.gov* and follow the online instructions at that site for submitting comments.
Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on *https://www.regulations.gov.* If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this is notice that on November 11, 2022, Isosciences, LLC, 340 Mathers Road, Ambler, Pennsylvania 19002-3420, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance(s):
Controlled substance Drug code Schedule Cathinone 1235 I Methcathinone 1237 I Lysergic acid diethylamide 7315 I Marihuana 7360 I Tetrahydrocannabinols 7370 I 3,4-Methylenedioxyamphetamine 7400 I 3,4-Methylenedioxy-N-ethylamphetamine 7404 I 3,4-Methylenedioxymethamphetamine 7405 I 5-Methoxy-N-N-dimethyltryptamine 7431 I Alpha-methyltryptamine 7432 I Bufotenine 7433 I Diethyltryptamine 7434 I Dimethyltryptamine 7435 I Psilocybin 7437 I Psilocyn 7438 I 5-Methoxy-N,N-diisopropyltryptamine 7439 I Dihydromorphine 9145 I Heroin 9200 I Nicocodeine 9309 I Nicomorphine 9312 I Normorphine 9313 I Thebacon 9315 I Normethadone 9635 I Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- phenylacrylamide) 9811 I Para-Fluorofentanyl 9812 I 3-Methylfentanyl 9813 I Alpha-methylfentanyl 9814 I Acetyl-alpha-methylfentanyl 9815 I N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4- yl)propionamide 9816 I Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N- phenylacetamide) 9821 I Butyryl Fentanyl 9822 I 4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1- phenethylpiperidin-4-yl)isobutyramide) 9824 I 2-methoxy-N-(1-phenethylpiperidin-4-yl)-N- phenylacetamide 9825 I Beta-hydroxyfentanyl 9830 I Beta-hydroxy-3-methylfentanyl 9831 I Alpha-methylthiofentanyl 9832 I 3-Methylthiofentanyl 9833 I Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- phenylfuran-2-carboxamide) 9834 I Thiofentanyl 9835 I Beta-hydroxythiofentanyl 9836 I N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2- carboxamide 9843 I Amphetamine 1100 II Methamphetamine 1105 II Codeine 9050 II Dihydrocodeine 9120 II Oxycodone 9143 II Hydromorphone 9150 II Hydrocodone 9193 II Isomethadone 9226 II Methadone 9250 II Methadone intermediate 9254 II Morphine 9300 II Thebaine 9333 II Levo-alphacetylmethadol 9648 II Oxymorphone 9652 II Thiafentanil 9729 II Alfentanil 9737 II Sufentanil 9740 II Carfentanil 9743 II Fentanyl 9801 II The company plans to manufacture bulk controlled substances for use in analytical testing.
In reference to drug codes 7360 (Marihuana) and 7370 (Tetrahydrocannabinols), the company plans to bulk manufacture these drugs as synthetics. No other activities for these drug codes are authorized for this registration. Matthew Strait, Deputy Assistant Administrator. [FR Doc. 2022-28205 Filed 12-27-22; 8:45 am]
Connectionstraces to 1
Traces to 1 document
Citation graph
cites case law
Notices
Notice of application
Cites 1Cited by 0 across 0 sources